Astrana Health (ASTH) 10-Q2023 Q1 Quarterly report

Filed: 10 May 23, 1:49pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Bad

New words: AllCare, assist, authorizing, bore, bought, CCHCA, ceiling, Chinese, collar, counterparty, decision, discontinue, effort, Eleanor, enable, enablement, EPS, floor, Hacienda, headcount, high, human, incentivize, infrastructure, intersegment, issuable, Leung, ninety, outcome, owner, PC, published, recast, recruit, rent, rental, renting, situation, smaller, Song, spectrum, subscription, substantive, successful, Sunny, Surgical, suspend, transparency, twelve, unallocated, unavailable, unique, urgent, Village, vision, wide, women, World

Removed: acquirer, agree, AIPBP, assuming, ASU, begin, budget, budgetary, capped, consolidating, continued, demand, derivative, disease, education, innovative, liable, managerial, marketing, mechanism, MWN, Numen, originated, owed, payee, payer, penalty, refunded, remained, run, satisfying, senior, setting, shown, significance, strictly, supported, Topic, ultimately, unsecured, Update, virtually

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated ASTH transcripts

ASTH similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICERS AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350.

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Thomas Lam, M.D., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Apollo Medical Holdings, Inc. for the quarter ended March 31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Apollo Medical Holdings, Inc.


Date:	May 10, 2023	/s/ Thomas Lam
		Thomas Lam Co-Chief Executive Officer and President (Principal Executive Officer)

I, Brandon Sim, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Apollo Medical Holdings, Inc. for the quarter ended March 31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Apollo Medical Holdings, Inc.


Date:	May 10, 2023	/s/ Brandon Sim
		Brandon Sim Co-Chief Executive Officer (Principal Executive Officer)

I, Chandan Basho, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Apollo Medical Holdings, Inc. for the quarter ended March 31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Apollo Medical Holdings, Inc.


Date:	May 10, 2023	/s/ Chandan Basho
		Chandan Basho Chief Financial Officer (Principal Financial Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.